Editöre Mektup
BibTex RIS Kaynak Göster

The importance of maternal age in IVF treatment

Yıl 2020, Cilt: 2 Sayı: 1, 31 - 32, 30.03.2020

Öz

The most crucial factor that determines the success of achieving pregnancy both in natural and assisted reproductive techniques is the age of women. The ovarian reserve, which shows the number and quality of residual ovarian follicles, plays a vital role in female fertility, and it is directly related to the female age.

Kaynakça

  • 1. Yin H, Jiang H, He R, Wang C, Zhu J, Cao Z. Cumulative live birth rate of advanced-age women more than 40 with or without poor ovarian response. Taiwan J Obstet Gynecol 2019; 58:201-205.
  • 2. American College of Obstetricians and Gynecologists Committee on Gynecologic Practice; Practice Committee of the American Society for Reproductive Medicine. Female age-related fertility decline. Committee Opinion No. 589. Obstet Gynecol. 2014; 123:719-721.
  • 3. La Marca A, Minasi MG, Sighinolfi G, et al. Female age, serum antimüllerian hormone level, and number of oocytes affect the rate and number of euploid blastocysts in in vitro fertilization/intracytoplasmic sperm injection cycles. Fertil Steril 2017; 108:777-783.e2.
  • 4. Minasi MG, Colasante A, Riccio T, et al. Correlation between aneuploidy, standard morphology evaluation and morphokinetic development in 1730 biopsied blastocysts: a consecutive case series study. Hum Reprod 2016; 31:2245-2254.
  • 5. Franasiak JM, Forman EJ, Hong KH, et al. The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertil Steril 2014; 101:656–663.
  • 6. Ubaldi FM, Cimadomo1 D, Vaiarelli A, et al. Advanced Maternal Age in IVF: Still a Challenge? The Present and the Future of Its Treatment. Front Endocrinol (Lausanne) 2019; 10:94.
  • 7. Vaiarelli A, Cimadomoa D, Ubaldi N, Rienzia L, Ubaldia FM. What is new in the management of poor ovarian response in IVF? Curr Opin Obstet Gynecol 2018; 30:155-162.
  • 8. Sunkara SK, Rittenberg V, Raine-Fenning N, Bhattacharya S, Zamora J, Coomarasamy A. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod 2011; 26:1768-1774.
  • 9. Cohen Y, Tannus S, Alzawawi N, Son WY, Dahan M, Buckett W. Poor ovarian response as a predictor for live birth in older women undergoing IVF. Reprod Biomed Online 2018; 36:435-441.
  • 10. Jirge PR. Poor ovarian reserve. J Hum Reprod Sci 2016; 9:63-69.
  • 11. Farr SL, Schieve LA, Jamieson DJ. Pregnancy loss among pregnancies conceived through assisted reproductive technology, United States, 1999-2002. Am J Epidemiol 2007; 165:1380-1388.
  • 12. Leader J, Bajwa A, Lanes A, et al. The Effect of Very Advanced Maternal Age on Maternal and Neonatal Outcomes: A Systematic Review. J Obstet Gynaecol Can 2018; 40:1208-1218.

IVF tedavisinde maternal yaşın önemi

Yıl 2020, Cilt: 2 Sayı: 1, 31 - 32, 30.03.2020

Öz

Gerek doğal yollarla gerekse yardımcı üreme teknikleriyle gebelik elde etme başarısını belirleyen en önemli faktör kadın yaşıdır. Rezidüel ovarian folliküllerin sayısını ve kalitesini gösteren ovarian rezerv, kadın fertilitesinde oldukça önemli rol oynar ve kadın yaşı ile direkt ilişkilidir.

Kaynakça

  • 1. Yin H, Jiang H, He R, Wang C, Zhu J, Cao Z. Cumulative live birth rate of advanced-age women more than 40 with or without poor ovarian response. Taiwan J Obstet Gynecol 2019; 58:201-205.
  • 2. American College of Obstetricians and Gynecologists Committee on Gynecologic Practice; Practice Committee of the American Society for Reproductive Medicine. Female age-related fertility decline. Committee Opinion No. 589. Obstet Gynecol. 2014; 123:719-721.
  • 3. La Marca A, Minasi MG, Sighinolfi G, et al. Female age, serum antimüllerian hormone level, and number of oocytes affect the rate and number of euploid blastocysts in in vitro fertilization/intracytoplasmic sperm injection cycles. Fertil Steril 2017; 108:777-783.e2.
  • 4. Minasi MG, Colasante A, Riccio T, et al. Correlation between aneuploidy, standard morphology evaluation and morphokinetic development in 1730 biopsied blastocysts: a consecutive case series study. Hum Reprod 2016; 31:2245-2254.
  • 5. Franasiak JM, Forman EJ, Hong KH, et al. The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertil Steril 2014; 101:656–663.
  • 6. Ubaldi FM, Cimadomo1 D, Vaiarelli A, et al. Advanced Maternal Age in IVF: Still a Challenge? The Present and the Future of Its Treatment. Front Endocrinol (Lausanne) 2019; 10:94.
  • 7. Vaiarelli A, Cimadomoa D, Ubaldi N, Rienzia L, Ubaldia FM. What is new in the management of poor ovarian response in IVF? Curr Opin Obstet Gynecol 2018; 30:155-162.
  • 8. Sunkara SK, Rittenberg V, Raine-Fenning N, Bhattacharya S, Zamora J, Coomarasamy A. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod 2011; 26:1768-1774.
  • 9. Cohen Y, Tannus S, Alzawawi N, Son WY, Dahan M, Buckett W. Poor ovarian response as a predictor for live birth in older women undergoing IVF. Reprod Biomed Online 2018; 36:435-441.
  • 10. Jirge PR. Poor ovarian reserve. J Hum Reprod Sci 2016; 9:63-69.
  • 11. Farr SL, Schieve LA, Jamieson DJ. Pregnancy loss among pregnancies conceived through assisted reproductive technology, United States, 1999-2002. Am J Epidemiol 2007; 165:1380-1388.
  • 12. Leader J, Bajwa A, Lanes A, et al. The Effect of Very Advanced Maternal Age on Maternal and Neonatal Outcomes: A Systematic Review. J Obstet Gynaecol Can 2018; 40:1208-1218.
Toplam 12 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Konular Kadın Hastalıkları ve Doğum
Bölüm Editöre Mektup
Yazarlar

Runa Özelçi

Yaprak Ustun

Yayımlanma Tarihi 30 Mart 2020
Kabul Tarihi 25 Mart 2020
Yayımlandığı Sayı Yıl 2020 Cilt: 2 Sayı: 1

Kaynak Göster

APA Özelçi, R., & Ustun, Y. (2020). IVF tedavisinde maternal yaşın önemi. Türk Kadın Sağlığı Ve Neonatoloji Dergisi, 2(1), 31-32.
AMA Özelçi R, Ustun Y. IVF tedavisinde maternal yaşın önemi. Türk Kadın Sağlığı ve Neonatoloji Dergisi. Mart 2020;2(1):31-32.
Chicago Özelçi, Runa, ve Yaprak Ustun. “IVF Tedavisinde Maternal yaşın önemi”. Türk Kadın Sağlığı Ve Neonatoloji Dergisi 2, sy. 1 (Mart 2020): 31-32.
EndNote Özelçi R, Ustun Y (01 Mart 2020) IVF tedavisinde maternal yaşın önemi. Türk Kadın Sağlığı ve Neonatoloji Dergisi 2 1 31–32.
IEEE R. Özelçi ve Y. Ustun, “IVF tedavisinde maternal yaşın önemi”, Türk Kadın Sağlığı ve Neonatoloji Dergisi, c. 2, sy. 1, ss. 31–32, 2020.
ISNAD Özelçi, Runa - Ustun, Yaprak. “IVF Tedavisinde Maternal yaşın önemi”. Türk Kadın Sağlığı ve Neonatoloji Dergisi 2/1 (Mart 2020), 31-32.
JAMA Özelçi R, Ustun Y. IVF tedavisinde maternal yaşın önemi. Türk Kadın Sağlığı ve Neonatoloji Dergisi. 2020;2:31–32.
MLA Özelçi, Runa ve Yaprak Ustun. “IVF Tedavisinde Maternal yaşın önemi”. Türk Kadın Sağlığı Ve Neonatoloji Dergisi, c. 2, sy. 1, 2020, ss. 31-32.
Vancouver Özelçi R, Ustun Y. IVF tedavisinde maternal yaşın önemi. Türk Kadın Sağlığı ve Neonatoloji Dergisi. 2020;2(1):31-2.